argenx SE ( ARGX) - Key Metrics
ARGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $39.56 | $14.38 | $6.30 | $6.29 |
| 2025Q2 | $13.36 | $3.46 | $5.10 | $5.03 |
| 2025Q1 | ? | ? | ? | ? |
| 2024Q4 | $18.97 | $11.78 | $0.57 | $0.56 |
| 2024Q3 | $9.54 | $1.52 | ? | ? |
ARGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 14.63 |
| 2025Q2 | ? | 40.03 |
| 2025Q1 | ? | ? |
| 2024Q4 | ? | 13.19 |
| 2024Q3 | ? | 89.08 |
ARGX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 0.79% | ? |
| 2025Q2 | 1.29% | ? |
| 2025Q1 | ? | ? |
| 2024Q4 | 0.11% | ? |
| 2024Q3 | ? | ? |
ARGX
Price: $874.74
52 week price:
Earnings Per Share: 22.54 USD
P/E Ratio: 36.08
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 205974
Ebitda: -24.6 millionMarket Capitalization: 56.9 billion